跳转至内容
Merck
CN
  • Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene.

Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene.

Translational psychiatry (2014-02-06)
A Ruiz, S Heilmann, T Becker, I Hernández, H Wagner, M Thelen, A Mauleón, M Rosende-Roca, C Bellenguez, J C Bis, D Harold, A Gerrish, R Sims, O Sotolongo-Grau, A Espinosa, M Alegret, J L Arrieta, A Lacour, M Leber, J Becker, A Lafuente, S Ruiz, L Vargas, O Rodríguez, G Ortega, M-A Dominguez, R Mayeux, J L Haines, M A Pericak-Vance, L A Farrer, G D Schellenberg, V Chouraki, L J Launer, C van Duijn, S Seshadri, C Antúnez, M M Breteler, M Serrano-Ríos, F Jessen, L Tárraga, M M Nöthen, W Maier, M Boada, A Ramírez
摘要

To follow-up loci discovered by the International Genomics of Alzheimer's Disease Project, we attempted independent replication of 19 single nucleotide polymorphisms (SNPs) in a large Spanish sample (Fundació ACE data set; 1808 patients and 2564 controls). Our results corroborate association with four SNPs located in the genes INPP5D, MEF2C, ZCWPW1 and FERMT2, respectively. Of these, ZCWPW1 was the only SNP to withstand correction for multiple testing (P=0.000655). Furthermore, we identify TRIP4 (rs74615166) as a novel genome-wide significant locus for Alzheimer's disease risk (odds ratio=1.31; confidence interval 95% (1.19-1.44); P=9.74 × 10(-)(9)).

材料
货号
品牌
产品描述

Sigma-Aldrich
Anti-TRIP4 antibody produced in rabbit, IgG fraction of antiserum